Alcon Loses Bid To Patent Improved Eye Drug At EPO
Alcon Research has lost its bid to patent a glaucoma treatment after European officials found that scientists would have already thought of using its claimed preservative to prevent microbial growth....To view the full article, register now.
Already a subscriber? Click here to view full article